Bristol Myers Says KarXT Was Generally Well Tolerated in Both Studies
Bristol Myers said KarXT was generally well tolerated across both studies, with no new safety signals identified.
Bristol Myers said KarXT was generally well tolerated across both studies, with no new safety signals identified.